Xeltis' Technology for Natural Heart Valve Restoration Featured as the Future of Valve Therapy at EuroPCR
Dedicated plenary session on Endogenous Tissue Restoration (ETR) previews first data from aortic valve preclinical studies
PARIS, May 17, 2017 -- (Healthcare Sales & Marketing Network) -- A pioneering approach to heart valve therapy from Swiss-Dutch cl... Devices, Interventional, Cardiology Xeltis , Endogenous Tissue Restoration, heart valve therapy
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news
More News: Cardiology | Heart | Heart Valve Disease | Heart Valves | Marketing | Pharmaceuticals | Study